Harnessing the potential of induced pluripotent stem cells for regenerative medicine (original) (raw)

• Briggs, R. & King, T. J. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl Acad. Sci. USA 38, 455–463 (1952).
  CAS PubMed PubMed Central Google Scholar
• Gurdon, J. B. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morphol. 10, 622–640 (1962).
  CAS PubMed Google Scholar
• Stadtfeld, M. & Hochedlinger, K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 24, 2239–2263 (2010).
  CAS PubMed PubMed Central Google Scholar
• Rideout, W. M. III, Hochedlinger, K., Kyba, M., Daley, G. Q. & Jaenisch, R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109, 17–27 (2002).
  CAS PubMed Google Scholar
• Schnieke, A.E. et al. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278, 2130–2133 (1997).
  CAS PubMed Google Scholar
• Hochedlinger, K. & Jaenisch, R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415, 1035–1038 (2002).
  CAS PubMed Google Scholar
• Lee, B. C. et al. Dogs cloned from adult somatic cells. Nature 436, 641 (2005).
  CAS PubMed Google Scholar
• Yin, X. J. et al. Cats cloned from fetal and adult somatic cells by nuclear transfer. Reproduction 129, 245–249 (2005).
  CAS PubMed Google Scholar
• Li, S., Chen, X., Fang, Z., Shi, J. & Sheng, H. Z. Rabbits generated from fibroblasts through nuclear transfer. Reproduction 131, 1085–1090 (2006).
  CAS PubMed Google Scholar
• Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
  Article CAS PubMed Google Scholar
• Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).
  CAS PubMed Google Scholar
• Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).
  CAS PubMed Google Scholar
• Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007).
  CAS PubMed Google Scholar
• Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 1–12 (2007).
  Google Scholar
• Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
  CAS PubMed Google Scholar
• Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008).
  CAS PubMed Google Scholar
• Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008).
  CAS PubMed Google Scholar
• Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).
  CAS PubMed PubMed Central Google Scholar
• Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008).
  CAS PubMed PubMed Central Google Scholar
• Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964–977 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472–476 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kaji, K. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771–775 (2009).
  CAS PubMed PubMed Central Google Scholar
• Haase, A. et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434–441 (2009).
  CAS PubMed Google Scholar
• Lowry, W.E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105, 2883–2888 (2008).
  CAS PubMed PubMed Central Google Scholar
• Loh, Y.H. et al. Generation of induced pluripotent stem cells from human blood. Blood 113, 5476–5479 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kunisato, A. et al. Direct generation of induced pluripotent stem cells from human non-mobilized blood. Stem Cells Dev. 20, 159–168 (2011).
  CAS PubMed Google Scholar
• Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276–1284 (2008).
  CAS PubMed Google Scholar
• Ebert, A. D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2009).
  CAS PubMed Google Scholar
• Carvajal-Vergara, X. et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808–812 (2010).
  CAS PubMed PubMed Central Google Scholar
• Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010).
  CAS PubMed Google Scholar
• Yazawa, M. et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230–234 (2011).
  CAS PubMed PubMed Central Google Scholar
• Marchetto, M. C. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527–539 (2010).
  CAS PubMed PubMed Central Google Scholar
• Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402–406 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zhang, J. et al. A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31–45 (2011).
  CAS PubMed Google Scholar
• Liu, G.H. et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature advance online publication, 10.1038/nature09879 (23 February 2011).
• Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920–1923 (2007).
  CAS PubMed Google Scholar
• Wernig, M. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856–5861 (2008).
  CAS PubMed PubMed Central Google Scholar
• Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30–e41 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nelson, T. J. et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408–416 (2009).
  PubMed PubMed Central Google Scholar
• Murry, C. E. & Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661–680 (2008).
  CAS PubMed Google Scholar
• Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443–452 (2008).
  CAS PubMed Google Scholar
• Song, Z. et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 19, 1233–1242 (2009).
  PubMed Google Scholar
• Green, M. D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–272 (2011).
  CAS PubMed PubMed Central Google Scholar
• Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).
  PubMed Google Scholar
• Wichterle, H., Lieberam, I., Porter, J. A. & Jessell, T. M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385–397 (2002).
  CAS PubMed Google Scholar
• Kobayashi, T. et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 142, 787–799 (2010).
  CAS PubMed Google Scholar
• Coffin, J. M. & Stoye, J. P. Virology. A new virus for old diseases? Science 326, 530–531 (2009).
  CAS PubMed PubMed Central Google Scholar
• Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S. & Eggan, K. C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637–648 (2008).
  CAS PubMed Google Scholar
• Marchetto, M. C. et al. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649–657 (2008).
  CAS PubMed Google Scholar
• McNally, E. M. New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annu. Rev. Med. 58, 75–88 (2007).
  CAS PubMed Google Scholar
• Nguyen, H. N. et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267–280 (2011).
  CAS PubMed PubMed Central Google Scholar
• Swistowski, A. et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28, 1893-1904 (2010).
  CAS PubMed PubMed Central Google Scholar
• Nizzardo, M. et al. Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol. Life Sci. 67, 3837–3847 (2010).
  CAS PubMed Google Scholar
• Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524–528 (2008).
  CAS PubMed Google Scholar
• van Laake, L. W. et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1, 9–24 (2007).
  PubMed Google Scholar
• Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015–1024 (2007).
  CAS PubMed Google Scholar
• Kattman, S. J. et al. Expression of Flk-1/KDR and PDGFR-α marks the emergence of cardiac mesoderm from mouse and human pluripotent stem cells. Cell Stem Cell 8, 228–240 (2011).
  CAS PubMed Google Scholar
• Irion, S. et al. Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells. Development 137, 2829–2839 (2010).
  CAS PubMed PubMed Central Google Scholar
• Choi, K.D. et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559–567 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lengerke, C. et al. Hematopoietic development from human induced pluripotent stem cells. Ann. N. Y. Acad. Sci. 1176, 219–227 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ma, Y. D., Lugus, J. J., Park, C. & Choi, K. Differentiation of mouse embryonic stem cells into blood. Curr. Protoc. Stem Cell Biol. Chapter 1, Unit 1F.4 (2008).
• D'Amour, K.A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005).
  CAS PubMed Google Scholar
• Borowiak, M. et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4, 348–358 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wu, X., Ding, S., Ding, Q., Gray, N. S. & Schultz, P. G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 126, 1590–1591 (2004).
  CAS PubMed Google Scholar
• Hao, J. et al. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 3, e2904 (2008).
  PubMed PubMed Central Google Scholar
• Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275–280 (2009).
  CAS PubMed PubMed Central Google Scholar
• Desbordes, S. C. et al. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2, 602–612 (2008).
  CAS PubMed PubMed Central Google Scholar
• Swijnenburg, R.J. et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl Acad. Sci. USA 105, 12991–12996 (2008).
  CAS PubMed PubMed Central Google Scholar
• Szabo, E. et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521–526 (2010).
  CAS PubMed Google Scholar
• Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375–386 (2010).
  CAS PubMed PubMed Central Google Scholar
• Efe, J. A. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13, 215–222 (2011).
  CAS PubMed Google Scholar
• Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987–1000 (1987).
  CAS PubMed Google Scholar
• Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035–1041 (2010).
  CAS PubMed PubMed Central Google Scholar
• Sachinidis, A. et al. Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc. Res. 58, 278–291 (2003).
  CAS PubMed Google Scholar
• Boheler, K. R. et al. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 91, 189–201 (2002).
  CAS PubMed Google Scholar
• Olivier, E. N., Qiu, C., Velho, M., Hirsch, R. E. & Bouhassira, E. E. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp. Hematol. 34, 1635–1642 (2006).
  CAS PubMed Google Scholar
• Ma, F. et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc. Natl Acad. Sci. USA 105, 13087–13092 (2008).
  CAS PubMed PubMed Central Google Scholar
• Domian, I. J. et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326, 426–429 (2009).
  CAS PubMed PubMed Central Google Scholar
• Madden, L.R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl Acad. Sci. USA 107, 15211–15216 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zimmermann, W. H. & Eschenhagen, T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc. Med. 17, 134–140 (2007).
  CAS PubMed Google Scholar
• Menasche, P. et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189–1200 (2008).
  PubMed Google Scholar
• Lunde, K. et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355, 1199–1209 (2006).
  CAS PubMed Google Scholar
• Janssens, S. et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113–121 (2006).
  PubMed Google Scholar
• Petersen, T. H. et al. Tissue-engineered lungs for in vivo implantation. Science 329, 538–541 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ott, H. C. et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 16, 927–933 (2010).
  CAS PubMed Google Scholar
• Uygun, B. E. et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 16, 814–820 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ott, H. C. et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213–221 (2008).
  CAS PubMed Google Scholar
• Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249–257 (2010).
  CAS PubMed PubMed Central Google Scholar
• Chin, M. H. et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111–123 (2009).
  CAS PubMed PubMed Central Google Scholar
• Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350–1353 (2009).
  CAS PubMed PubMed Central Google Scholar
• Deng, J. et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27, 353–360 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107, 4335–4340 (2010).
  CAS PubMed PubMed Central Google Scholar
• Feng, Q. et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704–712 (2010).
  PubMed Google Scholar
• Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27, 743–745 (2009).
  CAS PubMed Google Scholar
• Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175–181 (2010).
  CAS PubMed PubMed Central Google Scholar
• Newman, A. M. & Cooper, J. B. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258–262 (2010).
  CAS PubMed Google Scholar
• Polo, J. M. et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848–855 (2010).
  CAS PubMed PubMed Central Google Scholar
• Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106–118 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hussein, S.M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58–62 (2011).
  CAS PubMed Google Scholar
• Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521–531 (2010).
  CAS PubMed Google Scholar
• Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63–67 (2011).
  CAS PubMed PubMed Central Google Scholar
• Osafune, K. et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26, 313–315 (2008).
  CAS PubMed Google Scholar
• Bock, C. et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439–452 (2011).
  CAS PubMed PubMed Central Google Scholar
• Muller, F. J. et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 8, 315–317 (2011).
  PubMed PubMed Central Google Scholar
• Strauss, S. Geron trial resumes, but standards for stem cell trials remain elusive. Nat. Biotechnol. 28, 989–990 (2010).
  CAS PubMed Google Scholar
• Pearl, J. I. et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell 8, 309–317 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218–1221 (2008).
  CAS PubMed Google Scholar
• Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ku, S. et al. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability. Cell Stem Cell 7, 631–637 (2010).
  CAS PubMed PubMed Central Google Scholar
• Raya, A. et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53–59 (2009).
  CAS PubMed PubMed Central Google Scholar
• Urbach, A., Bar-Nur, O., Daley, G.Q. & Benvenisty, N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6, 407–411 (2010).
  CAS PubMed PubMed Central Google Scholar
• Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225–229 (2011).
  CAS PubMed Google Scholar
• Maehr, R. et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA 106, 15768–15773 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rashid, S. T. et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120, 3127–3136 (2010).
  CAS PubMed PubMed Central Google Scholar
• Yang, J. et al. Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J. Biol. Chem. 285, 40303–40311 (2010).
  CAS PubMed PubMed Central Google Scholar
• Chamberlain, S. J. et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl Acad. Sci. USA 107, 17668–17673 (2010).
  CAS PubMed PubMed Central Google Scholar